Martin Grimm

2.8k citations
81 papers · 2.2k indexed · h-index 28
Topics
Cancer Immunotherapy and Biomarkers (13 papers)Immunotherapy and Immune Responses (12 papers)Immune Cell Function and Interaction (12 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology

In The Last Decade

Martin Grimm

79 papers receiving 2.1k citations

Peers

Martin Grimm
Comparison fields: 5 of 119
  • Oncology 764
  • Molecular Biology 582
  • Immunology 569
  • Cancer Research 383
  • Surgery 336
Replace Xuzhen Hu with:
Xuzhen Hu United States
Takaaki Tsunematsu Japan
Oskar Hoffmann Austria
Mamoru Uemura Japan
Quan Liu China
Yue Wang China
Junji Matsuoka Japan
Nobuaki Yamanaka Japan
Takashi Ando Japan
Hideki Mizutani Japan
Martin Grimm relative to Xuzhen Hu United States Xuzhen Hu's profile →
Citations per field
00.5×3.3×
Xuzhen Hu · 1×
Citations per year

Countries citing papers authored by Martin Grimm

Since Specialization
Citations

This map shows the geographic impact of Martin Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Grimm more than expected).

Fields of papers citing papers by Martin Grimm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Grimm. The network helps show where Martin Grimm may publish in the future.

Co-authorship network of co-authors of Martin Grimm

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Grimm. A scholar is included among the top collaborators of Martin Grimm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Grimm. Martin Grimm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 34
2 13
3 30
4 49
5 74
6 14
7 34
8 4
9 3
10 9
11 17
12 78
13 49
14 18
15 31
16 28
17 162
18 142
19 19
20 17

About Martin Grimm

Martin Grimm is a scholar working on Oncology, Immunology and Transplantation, having authored 81 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (12 papers). The work is most often cited by research in Oncology (764 citations), Immunology (569 citations) and Transplantation (69 citations). Martin Grimm has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Siegmar Reinert, Adelheid Munz, Ana Maria Waaga-Gasser, P Weidmann, Andreas Meier, G Keusch, Peter Teriete, Martin Gasser, Thorsten Biegner and Z. Glück. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026